Protect Your Investment: Why Brainstorm Cell Therapeutics Inc. Investors Should Seek Counsel Before the Securities Class Action Deadline, According to Rosen National Investor Counsel
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline NEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) – ROSEN Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between August 15, 2022 and September 27, 2023, both dates…